This paper re p o rts the use of dexmedetomidine in three epileptic patients with cave rnous angiomas that underwent awake surg e ry in order to map their speech are a s . Method: L o a d i n g dose of dexmedetomidine varied from 1 µg/Kg/h to 3 µg/Kg/h over 20 minutes and maintenance dose fro m 0.4 µg/Kg/h to 0,8 µg/Kg/h. Results: There was no occurrence of hemodynamic instability, convulsions or re s p i r a t o ry depression. Patients tolerated well the pro c e d u re . Conclusion: Dexmedetomidine was useful f o r awake craniotomy as it decreased patients' level of consciousness but did not produce agitation. Lary n g e a l mask was not necessary to keep air ventilation.
Awake craniotomy is a useful technique when lesions near eloquent areas have to be re m o v e d 1 . U n f o rt u n a t e l y, pro c e d u re 's demands on patients a n d s u rgical team must not be neglected. Patients need to be fully alert and cooperative during testing b u t on the other hand, it is desirable to keep them sedated over the rest of surg e ry avoiding unnecess a ry discomfort and anxiety. It is a delicate balance, even on experienced hands, as re s p i r a t o rydep ression also has to be taken in account. To accomplish adequate level of sedation and analgesia both local and systemic anesthetics are used. A combination of opioids and midazolan associated, or n o t , to propofol or droperidol is effective. But, despite s a t i s f a c t o rylevel of stress for patients, small pro blems like agitation, drowsiness, seizure or pain still occur in 48% of the surgeries 2 . Dexmedetomidine hydrochloride is a selective alpha-2 adrenoceptor agonist with centrally mediated sympatholytic and sedative effects. It is indicated for sedation of intubated and mechanically ventilated patients during treatment in intensive c a reunits. Dexmedetomidine decreases the needs of analgesia and produces a kind of sedation that patient can be easily roused by verbal stimuli 3 . These characteristics brought about its use for awake craniotomy in association with volatile anesthetic delivered by laryngeal mask 4, 5 . This paper re p o rts the anesthetic and surgical technique in three cases where dexmedetomidine h y d rochloride was used associated to fentanyl, midazolan and propofol for awake craniotomy and c o rtical mapping without laryngeal mask. To our knowledge this technique was not reported previously in the literature.
METHOD
S u rgical pro c e d u res were informed to patients as earlier as possible. Thus, they had time to form u l a t e questions and easy their anxieties before final surgical agreement. A psychological battery was conducted at bedside to identify patients' characteristics in order to improve language testing at the operating room.
P reoperative medication was not used and infusion of a loading dose of dexmedetomidine started following positioning of non invasive anesthesia monitors. An internal jugular vein, Foley catheter, and radial arterial line were inserted while on dexmedetomidine. The maintenance dose of the drug was tittered according to patients' needs. Oxygen delivery and monitoring of expiratory gas CO2 concentrations were obtained via a nasal cannula. Comf o rtable positioning was an essential step to avoid peripheral nerve injuries. A three pin head holder was placed after head block using 0.5% lidocaine, 0.25% bupivacaine with epinephrine (1:200,000) and saline. Surgical incision and skin flap base were anesthetized with the same solution. Patients were positioned laterally, with heads almost parallel to the ground and draping adjusted to keep eyes and airways easily accessible.
Patients underwent electro c o rticography (ECoG) using a 32-channel Nicolet alliance portable unit (Nicolet BMSI, Inc. Madison, WI, USA) to identify epileptogenic a reas near the lesions. Brain mapping was perf o rm e d using an Ojemann cortical stimulator (Radionics Corp., Burlington, MA, USA) with a monopolar probe. Curre n t s w e re delivered with single pulse of 1 millisecond and frequency of 60 Hz.
All patients stayed calm and cooperative during the p ro c e d u re. On the day after, they were all able to re c a l l verbal testing but kept no unpleasant fillings about it. No patient developed new deficits after surgery.
The technique is a variation of the standard of care since dexmedetomidine has been proved safe for human use, although with a diff e rent set up. The study was approved by the institutional review board.
Case 1 -Male, 28 years old (weight 49.5 Kg) pre s e n ted 8 months prior surg e ry with a transitory mild dysphasia and generalized seizures. CT scan showed a small hem o rrhage on the left temporal lobe and MRI disclosed a c a v e rnous angioma within the supramarginal gyrus. He went to surg e ry on phenitoin, 300mg per day. Using a temporal horseshoe incision, the sensorial and motor a reas were mapped, with 5 mAmp, and the cavern o u s angioma removed.
A dexmedetomidine loading dose of 3 µg/Kg/h over 20 minutes was infused and maintained with 0.5 µg / K g / h . During temporal muscle retraction patient complained and the dose was elevated to 0,8 µg/Kg/h. As he became too dro w s y, the drug was discontinued for 15 minutes and then resumed at 0.3 µg/Kg/h for speech evaluation and maintained at this level to the end of surgery. Boluses of fentanyl (total of 300 µg), propofol (total of 150 mg), and midazolan (total 3 mg) were used when judged n e c e s s a ry. The pro c e d u re took 5 hours and 45 minutes.
Case 2 -Female, 45 years old (weight 75 Kg). About 1 month prior surg e ry she presented with re c u rrent focal s e i z u res and a mild dysphasia. Prolonged EEG showed p e rsistent ictal activity on the left temporal lobe which ceased after was put on carbamazepine 800 mg and clonazepan 2 mg per day. MRI identified a subcortical cavernous angioma in the left angular gyrus.
Craniotomy was perf o rmed over the temporal lobe with a horseshoe incision. Speech area was identified by 7mAmp monopolar stimulation on the cortex over t h e lesion. Spikes were seen on ECoG on the angular gyru s . The cavernous angioma was then removed while pre s e rving at most its surroundings.
Dexmedetomidine was infused for 20 minutes at the dose of 3 µg/Kg/h and then set at 0.5 µg/Kg/h thro u g hout the surg e ry. Boluses of fentanyl (total of 800µg), midazolan (total 15 mg), propofol (total 300 mg), and droperidol (2.5mg) were used along the procedure, which lasted 8 hours and 15 minutes. The higher than usual dose was employed because patient was very anxious and asked for something "stronger", then an incre a s e in the dosage of dexmedetomidine was considered.
Case 3 -Male, 35 years old (weight 61.5 Kg) pre s e n ted with generalized seizures at night, treated with phenitoin 300 mg per day. During investigation, a cavern o u s angioma was identified occupying part of the inferior left frontal gyrus in close relation to the Sylvian fissure.
A frontotemporal craniotomy was perf o rmed thro u g h a pterional incision. After splitting the Sylvian fissure all branches to the cavernous angioma were isolated and cut before its resection. Speech area was found behind the lesion with 5mAmp stimulation. ECoG demonstrate d no spikes.
Dexmedetomidine at dose of 1 µg/Kg/h was used over 20 minutes and reduced to a maintenance dose of 0.4 µg/Kg/h till the rest of surg e ry. Boluses of midazolan (total of 15 mg) and fentanyl (total of 600 µg) were used t o keep patients' comfort over the 9 hours of pro c e d u re .
DISCUSSION
Dexmedetomidine re p resents a new paradigm in anesthesia. While most sedative drugs operate on GABA receptors, dexmedetomidine is an alpha-2 adrenergic agonist which sedates through its action at the locus coeruleus 6 . Diff e rent from GABA, alpha-2 adre n o receptors produces sedation without the entire spectrum of stupor, which may be associated with paradoxical agitation. At clinical doses, patients stay somnolent but not distressed or confused and can be easily roused with verbal s t imuli becoming prompt to be tested 3 .
Anxiety is a common inconvenient when dealing with awake surg e ry. Dexmedetomidine has an anxiolytic effect, probably related to its re d u c t i o n of sympathetic responses to stress both at the central and peripheral nervous system 7 , 8 . Indeed, our impression is that patients on this drug were less a p p rehensive than expected. We kept doses fro m 0.3 to 0.8 µg/Kg/h, but the highest dose, used on c ase 1, produced undue somnolence and had to be reduced. In contrast to other studies 9 , 1 0 , we had neither significant hemodynamic instability nor brad yc a rdia in our series. We suppose it happens due to d i ff e rences in drugs associations or, as patients are awake, an increase on blood level of catecholam i n e s may occur, avoiding excessive sympathetic blocka g e .
Pain control is also a special challenge for the s u rgical team. Usually particularly painful surgical s t e p s a re the temporal muscle retraction and the detachment of cranial bone from dura mater near the t e mporal fossa. At those points patients frequently req u i re an increase in analgesia, which may bring o u t d rowsiness. As brain mapping is done shortly after c r a n i o t o m y, time may be needed for re c o v e r i n g b e f o re verbal testing, increasing total length of s u rg e ry. Patients on dexmedetomidine need less analgesic dru g s 1 1 , which improved the quality and duration of our intra operative neuro p s y c h o l o g i c a l assessment.
T h e re was no significant oxygen desaturation or hypercapnia within our group in accord a n c e with literature 1 2 . Spontaneous ventilation associated to fluid balance was enough to keep the brain a p p ropriate for micro s u rg e ry. Laryngeal mask was not necessary and was not used in any patient.
T h e re is evidence that dexmedetomidine dec reases the seizure threshold in animal models 1 3 , 1 4 . It has not been described in humans yet but has to be taken into account as most patients who und e rgo awake surg e ry already have epilepsy. More o v e r, cortical stimulation also increases the risk o f convulsions. Anesthetists need to be aware and p re p a red to treat convulsive incidents. In our cases we had no intra operative seizures.
In conclusion, dexmedetomidine is a useful dru g for awake craniotomy as it decreases patients' anxie t y, pain medication needs, and level of consciousness without agitation. The drug causes no significant re s p i r a t o rydepression and need not be used associated to laryngeal mask. The importance of i t s convulsant pro p e rties still has to be assessed in the future.
